5.2 Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus and Other Ketoacidosis In patients with type 1 diabetes mellitus, empagliflozin, a component of SYNJARDY or SYNJARDY XR, significantly increases the risk of diabetic ketoacidosis, a life-threatening event, beyond the background rate
In addition, consistent with our current knowledge of intestinal FXR signaling and our hypothesis, the GLP-1 production was increased, while the glucose metabolism was improved in MMI-treated IFXRKO mice as compared to MMI-treated Floxed mice (Fig
Responding to the urge promptly rather than delaying it also matters, because repeatedly ignoring the signal gradually trains the body to suppress it
Epidemiology and etiology Prevalence, incidence, and mortality rates in different regions According to global epidemiological data (cases per 100,000 people per year), the overall incidence of AP is 33.74 (95% CI: 23.3348.81)